PATENT CLAIM ANALYSIS

Application Number: 16298762
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "293000"]

Abstract:
A novel class of fluorinated derivatives of Formula I have been prepared and found to be useful in the treatment of cancers and other disorders related mediated by Bromodomain-Containing Proteins.

Claim (Index 18):
The compound of  claim 1 , selected from: or a pharmaceutically acceptable salt, solvate and/or prodrug thereof.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 99.0
- Lexical Diversity: 1.10714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15546324', '15619671', '15749950', '14204076', '15150492']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.813953494554252
- 35 USC 102 Novelty (BERT): 0.5465304818584703
- Combined Prediction Score: 0.7872111932846739
- Mean Citation Score: 341.494826
- Max Citation Score: 400.17456
- Similarity Product: 338.72137623250006

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test